Olink® Target 96 Inflammation Panels

Thoroughly validated, high-performance protein biomarker panels for inflammation studies.

Olink® Target 96 panels specialize in key disease areas and important biological processes, and accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.


Key features & benefits

  • Allows for simultaneous analysis of 92 protein biomarkers
  • Uses only 1 µL of biological sample
  • Exceptional data quality through relative (NPX) quantification
  • qPCR readout with unparalleled sensitivity, specificity, and precision
  • All assays are subject to Olink’s strict technical validation and quality control procedures

The Olink Target 96 Inflammation panel offers a broad selection of proteins associated with inflammatory and immune response processes. Categorization of the proteins included in the panel was carried out via referral to widely used public-access bioinformatic databases, including Uniprot, Human Protein Atlas, Gene Ontology (GO) and DisGeNET.


Accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.
Learn more about the Olink Target platform.

How does it work?

The unique technology behind the Olink platforms, Proximity Extension Assay (PEA) technology, is an innovative dual recognition, DNA-coupled methodology providing exceptional readout specificity. PEA enables high multiplex, rapid throughput biomarker analysis without compromising on data quality.


Read more about how Olink technology delivers this scale of multiplexing and sample throughput without compromising on data quality or assay robustness.

The Olink biomarker assay panels are available with the flexibility to best suit your needs. You can choose whether to purchase the panels as kits and run them in your own lab, or send your sample the experts at one of the many trained labs around the world offering sample analysis service.


Olink Target 96 Inflammation ( 92 )

This represents the most extensive panel available on the market for proteins associated with inflammatory diseases and related biological processes, enabling investigation of protein signatures with high efficiency and robustness and accelerates the speed of finding new and relevant human protein biomarkers related to inflammation. The panel is compiled to detect a selection of already established as well as exploratory biomarkers within the inflammation research field.

The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.

'; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; '; ';

A benchtop system for protein biomarker analysis

Olink® Signature Q100 is a user-friendly instrument for readout of all Olink® Target and Olink® Focus protein biomarker panels. Learn more about this benchtop solution and how to streamline your protein biomarker analysis.

Browse the entire Olink library of high quality, thoroughly validated protein biomarker assays. Search by Uniprot ID, protein name, alternative protein name or gene name.

To view more detailed information on Olink panels, you can download full validation data information for all Olink panels in the document download center.

Access all the latest technical user documentation to learn more about the functionalities of Olink products and solutions, including manuals, short instructions and guidelines.

Our analysis service offers high-capacity analysis of your samples using our Olink Explore or Olink Target platforms for protein biomarker analysis.

See what other visitors asked, to learn more about Olink technology, services and science. Search our library of information or contact our Customer Support for assistance.